DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations.
Federico InnocentiWancen MuXueping QuFang-Shu OuOmar KabbarahCharles David BlankeAlan P VenookHeinz-Josef LenzNaim U RashidPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
These results can provide new tools to predict patient outcome and improve therapeutic decisions and trial participation in patient minorities. The molecular alterations identified in this study may direct biomarker-driven studies.